EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review

Joseph M Pappachan, Bhuvana Sunil, Cornelius J Fernandez, Ian M Lahart, Ambika P Ashraf

Endocrinology · 2022

DOI: 10.17925/ee.2022.18.1.2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endocrinology, 2022. Verfasst von Joseph M Pappachan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology & Metabolism, Lancashire Teaching Hospitals NHS Trust, Preston, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This article is published under the Creative Commons Attribution Non-commercial License..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To examine the accuracy of urine c-peptide creatinine ratio (UCPCR) for identifying the type of diabetes in appropriate clinical settings.

Design

Systematic review of test accuracy studies on patients with different forms of diabetes. Data sources : Medline, Embase and Cochrane library databases from 1 January 2000 to 15 November 2020. Eligibility criteria : Studies reporting the use of UCPCR for diagnosing patients with type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM) and monogenic forms of diabetes (categorized as maturity-onset diabetes of the young [MODY]). Study selection and data synthesis : Two reviewers independently assessed articles for inclusion and assessed the methodological quality of the studies using the Quality Assessment of Diagnostic Accuracy Studies-2 tool, with input from a third reviewer to reach consensus when there was a dispute. Meta-analysis was performed with the studies reporting complete data to derive the pooled sensitivity, specificity and diagnostic odds ratio (DOR), and narrative synthesis only for those with incomplete data.

Results

Nine studies with 4,488 patients were included in the qualitative synthesis, while only four of these (915 patients) had complete data and were included in the quantitative synthesis. All the studies had moderate risk of bias and applicability concerns. Meta-analysis of three studies (n=130) revealed sensitivity, specificity and DOR of 84.4% (95% confidence interval [CI] 68.1–93.2%), 91.6% (82.8–96.1%) and 59.9 (32.8–106.0), respectively, for diagnosing T1DM using a UCPCR cut-off of 0.2 nmol/mmol was associated with sensitivity, specificity and DOR of 92.8% (84.2–96.9%), 81.6% (61.3–92.5%) and 56.9 (31.3–103.5), respectively. For patients with MODY in the appropriate clinical setting, a UCPCR cut-off of >0.2 nmol/mmol showed sensitivity, specificity and DOR of 85.2% (73.1–92.4%), 98.0% (92.4–99.5%) and 281.8 (57.5–1,379.7), respectively.

Conclusions

Based on studies with moderate risk of bias and applicability concerns, UCPCR confers moderate to high sensitivity, specificity, and DOR for correctly identifying T1DM, T2DM and monogenic diabetes in appropriate clinical settings. Large multinational studies with multi-ethnic participation among different age groups are necessary before this test can be routinely used in clinical practice. Study registration : Protocol was registered as PROSPERO CRD42017060633.

Schlagwörter

Stichwörter der Autor:innen

C-peptideendogenous insulin reservematurity-onset diabetes of the young (MODY)monogenic diabetestype 1 diabetes mellitus (T1DM)type 2 diabetes mellitus (T2DM)urine C-peptide creatinine ratio (UCPCR)

Autor:innen und Institutionen

  • Department of Endocrinology & Metabolism, Lancashire Teaching Hospitals NHS Trust, Preston, UK.
  • Faculty of Science, Manchester Metropolitan University, Manchester, UK.
  • Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Division of Pediatric Endocrinology & Diabetes, Mary Bridge Children's Hospital, Tacoma, WA, USA.
  • Department of Endocrinology & Metabolism, Pilgrim Hospital, Boston, UK.
  • Faculty of Education, Health and Wellbeing, University of Wolverhampton, Walsall, UK.

Förderung

  • This article is published under the Creative Commons Attribution Non-commercial License.

Zitieren

APA

Pappachan, J. M., Sunil, B., Fernandez, C. J., Lahart, I. M., & Ashraf, A. P. (2022). Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review. Endocrinology. https://doi.org/10.17925/ee.2022.18.1.2

Vancouver

Pappachan JM, Sunil B, Fernandez CJ, Lahart IM, Ashraf AP. Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review. Endocrinology. 2022. doi:10.17925/ee.2022.18.1.2

BibTeX
@article{Pappachan2022,
  author = {Pappachan, Joseph M and Sunil, Bhuvana and Fernandez, Cornelius J and Lahart, Ian M and Ashraf, Ambika P},
  title = {Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review},
  journal = {Endocrinology},
  year = {2022},
  doi = {10.17925/ee.2022.18.1.2}
}
Kostenlos starten →